Consistent with this idea, genetic disorders that impair GATA1 function often result in both the dysregulation of erythropoiesis as well as an increased incidence of transient myeloproliferative disorder and/or acute megakaryoblastic leukemia in a subset of patients18. This evidence concerns the gene GATA1 and hereditary disease.